Actionable news
0
All posts from Actionable news
Actionable news in ACAD: ACADIA Pharmaceuticals Inc.,

Buy Acadia's Undervalued Options Before Earnings

ACADIA Pharmaceuticals Inc. (ACAD) is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system disorders. The company's lead drug candidate, NUPLAZID (pimavanserin), is under development for the treatment of Parkinson's disease psychosis (PDP). NUPLAZID is a selective serotonin inverse agonist (SSIA), targeting 5-HT2A receptors. It is reporting earnings on Thursday, August 4, after market close:

(Source: TD Waterhouse)

As evident from the above, the company beat earnings estimates in 13% of time in the last two quarters, underperforming in 87% of time,and...


More